Cannabis

Cannabis and hemp-derived products, including medical and adult-use marijuana, subject to regulation on cultivation, processing, testing, contaminants, and market access.

Foresight tracks Cannabis developments and surfaces the alerts most likely to matter before they turn into missed deadlines, recalls, or escalation work.

Not ready for a trial? Take the 3-minute readiness assessment

Current activity

Steady

In line with the prior 8-week baseline

3-month trend

Latest alerts below

Last updated

25 May 2026, 15:34

View alerts

Latest Cannabis developments

Source-backed regulatory and guidance signals tracked by Foresight, with the newest developments first.

New Jersey Senate Committee Advances A5051 On Hemp, Intoxicating Hemp Beverages, And Medical Cannabis

New Jersey’s Assembly Bill A5051, which tightens rules for hemp, intoxicating hemp beverages and medical cannabis, has cleared Senate committee and reached second reading as of late May 2026. If enacted, it would extend key transition dates, harden packaging and testing standards, and narrow how and where intoxicating hemp beverages can be sold, meaning hemp beverage manufacturers and alcohol and cannabis retailers should prepare for more prescriptive state-level controls and potential channel restrictions.

pub.njleg.govUnited StatesUnited States

Michigan CRA Updates Metrc Virtual Transfer Guidance on Inventory Responsibility

Michigan’s Cannabis Regulatory Agency has immediately tightened its Metrc virtual transfer policy, making receiving licensees fully responsible for correcting inventory discrepancies once packages are accepted into their Metrc accounts. This change increases compliance and record-keeping risk for Michigan cannabis businesses, which must now rely on Metrc package adjustments or physical returns while expecting virtual transfers to be granted only in narrowly defined error scenarios.

michigan.govUnited StatesUnited States

Delaware Hemp Regulation Act (HB 401) Fails To Gain Committee Release Signatures

In May 2026, Delaware’s proposed Hemp Regulation Act (HB 401), which would create a comprehensive licensing, testing, labelling, age-restriction, and taxation regime for hemp-derived cannabinoid products, failed to secure the signatures needed for release from its House committee. This setback lowers the immediate likelihood of enactment but signals that stringent regulation of hemp-derived products, including 21+ age limits, mandatory potency testing, child-safe labelling, and a 6% excise tax, remains a live policy direction that could re-emerge in future sessions.

legis.delaware.govUnited StatesUnited States

Ukraine Economy Ministry Order No. 5889 Adds Agriculture and Food Safety Projects to 2026 Regulatory Work Plan

In May 2026, Ukraine’s Ministry of Economy, Environment and Agriculture adopted Order No. 5889 updating its 2026 regulatory work plan with new agriculture, veterinary, food safety and business support projects scheduled between May and December. These additions foreshadow upcoming draft measures on animal identification, industrial hemp oversight, veterinary medicines, animal feed controls and fee structures, giving agri-food and veterinary businesses early visibility of areas where rules and costs may change.

me.gov.uaUkraineUkraine

New Jersey Assembly Passes A5051 on Hemp, Intoxicating Hemp Beverages, and Medical Cannabis

In May 2026, the New Jersey Assembly passed Bill A5051 to tighten controls on hemp-derived cannabinoids, intoxicating hemp beverages, and aspects of medical cannabis licensing, and sent it to the Senate Judiciary Committee. If enacted, the measure would impose stricter THC content and packaging standards, extend temporary allowances to November 2026, and lock in new permissions for some dispensaries, forcing beverage, cannabis, and retail operators in New Jersey to reassess products, distribution, and compliance timelines.

pub.njleg.govUnited StatesUnited States

Minnesota Senate Passes Omnibus Cannabis Bill Tightening Licensing, THC Limits, and Labelling

The Minnesota Senate has narrowly passed SF 4401, a far‑reaching omnibus cannabis bill that would overhaul licensing (including a new macrobusiness tier) and tighten THC potency, packaging, and labelling rules for both adult‑use cannabis and lower‑potency hemp edibles, but the measure still awaits House action and is not yet law. If enacted, cannabis and hemp businesses in Minnesota would face stricter serving‑size and THC limits, expanded health warnings and packaging requirements, and new endorsement‑based licence structures, requiring early planning to adjust product formulations, labelling, and licensing strategies ahead of staged effective dates.

revisor.mn.govUnited StatesUnited States

New Jersey Assembly Advances Bill A5051 On Hemp, Intoxicating Hemp Beverages, And Medical Cannabis

New Jersey Assembly committees have advanced Bill A5051 (Aca, 1R), a detailed package revising state rules for hemp producers, intoxicating hemp beverages, and medical/adult-use cannabis licensing, moving it to second reading in May 2026. If enacted, the bill would extend key THC-related transition dates, tighten packaging, testing and sales-channel controls for intoxicating hemp beverages, and ease co-location and licensing of medical and adult-use dispensaries, requiring affected businesses to plan for potential operational changes by late 2026.

njleg.state.nj.usUnited StatesUnited States

Oklahoma Legislature Passes SJR53 Approving Major Permanent Rules of Oklahoma Medical Marijuana Authority

Oklahoma lawmakers have passed joint resolution SJR53 to approve a package of major permanent rules issued by the Oklahoma Medical Marijuana Authority and have sent the measure to the Governor in May 2026. If signed, this will lock in OMMA’s core rule framework for the state’s medical marijuana programme, so licensees should closely review the approved OAC 442:10 provisions for operational and compliance impacts once they take effect.

oklegislature.govUnited StatesUnited States

Vermont House Refers Bill S.323 on Agricultural, Pesticide, Seed, and Hemp Reforms to Appropriations Committee

Vermont’s omnibus agriculture bill S.323, which would tighten pesticide licensing, impose new registration and reporting duties for treated and genetically engineered seed, shift hemp and cannabinoid oversight to the Cannabis Control Board, and adjust farm, water and energy-siting rules, has been referred from the House floor to the Appropriations Committee following Senate passage and initial House review, with a proposed effective date of 1 July 2026. If enacted broadly as passed by the Senate, the bill would create new compliance burdens for pesticide dealers and applicators, seed distributors, hemp and cannabinoid businesses, and larger farm and energy projects in Vermont, so affected operators should track the remaining House process closely and begin planning for system, labelling and reporting changes.

legislature.vermont.govUnited StatesUnited States

Brazil (ANVISA) Seizes Irregular Injectable Medicines and Bans Unregistered Cannabis Products

Brazil’s medicines regulator ANVISA has issued an enforcement resolution ordering the seizure of several unregistered injectable weight-loss and diabetes products, irregular lots of Mounjaro Kwikpen, unregistered cannabis-derived medicines and specific Kefazol injection lots, with immediate bans on their manufacture, sale, advertising and use. This marks a tightened crackdown on unregistered and poor-quality medicines in Brazil, requiring pharmaceutical manufacturers, distributors and online platforms to audit portfolios and promptly remove the named products and lots from supply and marketing channels to avoid enforcement risk.

gov.brBrazilBrazil

Vermont S.323 Moves to House Ways and Means, Proposing Pesticide, Seed, and Hemp Regulatory Changes

In May 2026, Vermont’s omnibus agriculture bill S.323, which bundles significant changes to pesticide applicator licensing, seed labelling and reporting, hemp regulation, and farm permitting, passed the Senate and advanced to the House Ways and Means Committee. If enacted with its current text from July 2026, these reforms would tighten data and oversight requirements for pesticide-treated and genetically engineered seeds, bring many hemp-derived cannabinoids under stricter cannabis-style controls, and reshape compliance duties and costs for farms, agri‑businesses, and energy developers operating in Vermont.

legislature.vermont.govUnited StatesUnited States

Oklahoma HB4248 Hemp Beverage Age-21 Sales Bill Recalled From Enrollment

Oklahoma’s HB4248 would set a 21+ age limit on sales of hemp-containing beverages, but after passing both chambers the House rescinded its fourth reading and signing on 6 May 2026 and recalled the bill from enrollment. Retailers and beverage manufacturers should monitor whether lawmakers re-advance or amend the bill, as a revived measure could quickly impose age-21 sales restrictions and new compliance obligations in the Oklahoma market.

oklegislature.govUnited StatesUnited States

South Carolina Bill H.5667 Would Create Apothecary Retailer Licences for Hemp-Derived Cannabinoid and Wellness Products

South Carolina has introduced Bill H.5667 (Apothecary Retailer Act) to create a new apothecary retailer licence category and impose age, THC-content and marketing controls on hemp-derived cannabinoid, smoking-cession and wellness products sold in specialist outlets. If enacted, this would establish a distinct retail channel outside alcohol law, requiring manufacturers and retailers of cannabinoid and wellness products to align product formulations, labelling, and distribution strategies with South Carolina-specific THC limits and age-verification rules.

scstatehouse.govUnited StatesUnited States

Oklahoma Legislature Sends HB 4454 Restricting Medical Marijuana Edibles to Governor

Oklahoma has sent HB 4454, an enrolled bill tightening design and labelling rules for medical marijuana edibles, to the Governor as of early May 2026. If enacted, cannabis processors and brands will need to remove child-appealing shapes and branding and upgrade THC serving labelling on edibles ahead of a 1 November 2026 compliance start.

oklegislature.govUnited StatesUnited States

Delaware Legislature Introduces Delaware Hemp Regulation Act for Hemp-Derived Cannabinoid Products (HB 401)

Delaware has introduced HB 401 to establish the Delaware Hemp Regulation Act, creating a comprehensive licensing, testing, labelling, and taxation framework for retail sales of hemp-derived cannabinoid products to adults 21 and over. If enacted, this would significantly tighten controls on hemp-derived cannabinoids in Delaware, requiring new testing and packaging compliance, age-gated retail operations, and readiness for a 6% excise tax within a year of enactment or final regulations.

legis.delaware.govUnited StatesUnited States

EU AGRI Committee To Debate Regulatory Harmonisation in the Hemp Sector

In early May 2026, the European Parliament's agriculture committee will debate regulatory harmonisation for the EU hemp sector, focusing on divergent national rules on using all parts of the plant and related Common Market Organisation reform aspects. This signals growing political momentum to remove legal uncertainty that constrains hemp's role in the EU bioeconomy and could shape future CAP and market-access rules for hemp-derived products.

europarl.europa.euEuropean UnionEuropean Union

EESC Opinion on Proposal to Amend Regulation (EU) No 1308/2013 (School Scheme, Protein Crops, Hemp and Marketing Standards)

In January 2026 the European Economic and Social Committee issued an opinion on the CMO reform proposal COM(2025)553, covering EU school food schemes, a new protein crops sector, hemp production rules, marketing standards and agri-food crisis preparedness. If taken up by the co-legislators, its recommendations would support risk-based regulation of hemp (including THC/CBD feed uses), stronger origin labelling and protected meat designations, and clearer timelines for transitioning EU school schemes and agri-food crisis mechanisms, reshaping planning for agricultural, food and hemp supply chains.

eur-lex.europa.euEuropean UnionEuropean Union

Norway Publishes Joint Guidance on CBD Rules Across Product Categories

Norway’s food and medicines regulators have issued joint guidance confirming that cannabis-derived CBD extracts remain classified as narcotics and that CBD is still banned in foods, drinks and supplements, with only tightly controlled uses in medicines and certain cosmetics using synthetic CBD. This consolidates existing EU and national rules and signals continued strict enforcement, so businesses selling CBD products in Norway need to reassess product portfolios, labelling and supply chains to avoid illegal offerings and potential seizures or sanctions.

mattilsynet.noNorwayNorway

Oklahoma Senate Passes HB 4248 to Prohibit Sale of Hemp Beverages to Persons Under 21

The Oklahoma Senate has now passed HB 4248, a bill that would bar sales of hemp‑containing beverages to anyone under 21, with a planned effective date of 1 November 2026 if enacted. Companies selling hemp drinks into Oklahoma should prepare to treat them as age‑restricted products, updating point‑of‑sale controls and retailer guidance well before the proposed effective date.

oklegislature.govUnited StatesUnited States

Germany (VG Würzburg) Annuls Bavarian KCanG Cannabis Permit Contaminant Limits And ID-Copy Duty

A Bavarian administrative court has partially annulled standard cannabis cultivation permit conditions under the new Consumption Cannabis Act, ruling that only a federal regulation may set contaminant limits and that mandatory copying of members’ ID cards breaches identity-card and data-protection law. For cannabis associations, laboratories, and regulators this weakens the immediate legal force of medicinal-style contaminant thresholds in Bavaria, while underscoring the need to monitor forthcoming federal § 17(4) KCanG regulations and align participation documentation and data-handling practices with this emerging case law.

gesetze-bayern.deGermanyGermany

Not a newsletter. Not a feed. Structured intelligence mapped to your business.

These are just a few of the most recent Cannabis alerts. Foresight tracks every jurisdiction, every day — and surfaces only what affects your portfolio, with full citations and evidence.

Start free trial

Topic context

How to read Cannabis regulatory activity

Definition

What is Cannabis?

Cannabis and hemp-derived products, including medical and adult-use marijuana, subject to regulation on cultivation, processing, testing, contaminants, and market access.

Industry relevance

Why it matters

Cannabis developments can change product scope, supplier expectations, market access, reporting duties, and risk ownership. Foresight tracks the signals early so teams can respond before obligations become urgent.

Foresight tracking

How Foresight monitors it

Foresight monitors official sources, extracts structured regulatory intelligence, and maps alerts to a customer's products, substances, markets, and priorities so teams see the relevant signal with source evidence for review.

Frequently asked questions

Everything you need to know about Foresight's regulatory intelligence platform

Still have questions? Get in touch with our team

Join 3,500+ professionals staying ahead

Subscribe to Foresight Weekly for expert-picked regulatory developments across chemicals, sustainability, product safety, ESG, and HSE.

Free forever. Unsubscribe anytime.

Read by professionals at

Boeing
AstraZeneca
Siemens
PepsiCo
SpaceX